» Articles » PMID: 26569333

Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies

Overview
Date 2015 Nov 17
PMID 26569333
Citations 411
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is gaining acceptance as a serious primary health burden that impairs the quality of life because of its associated complications, including diabetes, cardiovascular diseases, cancer, asthma, sleep disorders, hepatic dysfunction, renal dysfunction, and infertility. It is a complex metabolic disorder with a multifactorial origin. Growing evidence suggests that oxidative stress plays a role as the critical factor linking obesity with its associated complications. Obesity per se can induce systemic oxidative stress through various biochemical mechanisms, such as superoxide generation from NADPH oxidases, oxidative phosphorylation, glyceraldehyde auto-oxidation, protein kinase C activation, and polyol and hexosamine pathways. Other factors that also contribute to oxidative stress in obesity include hyperleptinemia, low antioxidant defense, chronic inflammation, and postprandial reactive oxygen species generation. In addition, recent studies suggest that adipose tissue plays a critical role in regulating the pathophysiological mechanisms of obesity and its related co-morbidities. To establish an adequate platform for the prevention of obesity and its associated health risks, understanding the factors that contribute to the cause of obesity is necessary. The most current list of obesity determinants includes genetic factors, dietary intake, physical activity, environmental and socioeconomic factors, eating disorders, and societal influences. On the basis of the currently identified predominant determinants of obesity, a broad range of strategies have been recommended to reduce the prevalence of obesity, such as regular physical activity, ad libitum food intake limiting to certain micronutrients, increased dietary intake of fruits and vegetables, and meal replacements. This review aims to highlight recent findings regarding the role of oxidative stress in the pathogenesis of obesity and its associated risk factors, the role of dysfunctional adipose tissue in development of these risk factors, and potential strategies to regulate body weight loss/gain for better health benefits.

Citing Articles

Unlocking Fertility: How Nitric Oxide Pathways Connect Obesity and Reproductive Health-The Role of Bariatric Surgery.

Voros C, Mavrogianni D, Bananis K, Varthaliti A, Papahliou A, Topalis V Antioxidants (Basel). 2025; 14(2).

PMID: 40002424 PMC: 11851409. DOI: 10.3390/antiox14020240.


Energy Intake-Dependent Genetic Associations with Obesity Risk: BDNF Val66Met Polymorphism and Interactions with Dietary Bioactive Compounds.

Zhang T, Park S Antioxidants (Basel). 2025; 14(2).

PMID: 40002356 PMC: 11851519. DOI: 10.3390/antiox14020170.


Investigation of calonysterone and 20-hydroxyecdysone effects in high-fat, high-sugar diet-induced obesity rat model.

Osman A, Laczko D, Vagvolgyi M, Seres-Bokor A, Sztojkov-Ivanov A, Kemeny K Heliyon. 2025; 11(3):e42435.

PMID: 39991217 PMC: 11847253. DOI: 10.1016/j.heliyon.2025.e42435.


Management of cardiovascular disease by cerium oxide nanoparticles via alleviating oxidative stress and adipokine abnormalities.

Bashandy S, Elbaset M, Ibrahim F, Abdelrahman S, Moussa S, El-Seidy A Sci Rep. 2025; 15(1):5709.

PMID: 39962072 PMC: 11833101. DOI: 10.1038/s41598-025-85794-6.


Exploring the application of dietary antioxidant index for disease risk assessment: a comprehensive review.

Pourmontaseri H, Bazmi S, Sepehrinia M, Mostafavi A, Arefnezhad R, Homayounfar R Front Nutr. 2025; 11:1497364.

PMID: 39885868 PMC: 11781229. DOI: 10.3389/fnut.2024.1497364.


References
1.
Bendsen N, Hother A, Jensen S, Lorenzen J, Astrup A . Effect of dairy calcium on fecal fat excretion: a randomized crossover trial. Int J Obes (Lond). 2008; 32(12):1816-24. DOI: 10.1038/ijo.2008.173. View

2.
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S . Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8(11):1288-95. DOI: 10.1038/nm788. View

3.
Esposito K, Ciotola M, Giugliano F, Bisogni C, Schisano B, Autorino R . Association of body weight with sexual function in women. Int J Impot Res. 2007; 19(4):353-7. DOI: 10.1038/sj.ijir.3901548. View

4.
Barb D, Williams C, Neuwirth A, Mantzoros C . Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr. 2008; 86(3):s858-66. DOI: 10.1093/ajcn/86.3.858S. View

5.
Briffa J, McAinch A, Poronnik P, Hryciw D . Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol. 2013; 305(12):F1629-36. DOI: 10.1152/ajprenal.00263.2013. View